Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy

Keehoon Jung(Seoul National University), Dai Fukumura(Harvard University)
Journal of Clinical Investigation
July 9, 2017
Cited by 164


Related Papers